Ibuprofen Versus Placebo For Muscle Soreness

Jean Brown Research31 enrolled

Overview

The study will assess the sensitivity of the Delayed Onset Muscle Soreness Model by comparing the safety and efficacy of oral ibuprofen to placebo over 24 hours.

This is a double-blind, randomized, placebo controlled, parallel group, pilot safety and efficacy study. Healthy male or female subjects who have a history of occasional muscle soreness and are not currently exercising will be asked to volunteer for the study. All subjects will complete an informed consent process prior to study procedures. The study duration is anticipated to be approximately 4 months. Each subject may be in the study for up to 45 days including screening, run-in, inpatient and outpatient dosing and assessments, follow-up visit and follow-up telephone contact.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Muscle Soreness

Interventions

Ibuprofen 400 mgDRUG

Subjects will receive 4 doses of oral ibuprofen over a 24 hour period.

PlaceboOTHER

Subjects will receive 4 doses of placebo over a 24 hour period.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Subjects must meet the following criteria to be included in the study: 1. Male or female subjects aged 18-55 years; 2. In good general health; 3. Non-pregnant, non-lactating female subjects must be: 1. physically incapable of childbearing potential (postmenopausal for more than 1 year or surgically sterile) or 2. practicing an acceptable method of contraception (hormonal, barrier with spermicide, intrauterine device, vasectomized or same sex partner, or abstinence). Subjects using hormonal birth control must have been on a stable dose of treatment for at least 30 days and received at least 1 cycle of treatment prior to randomization. 4. History of experiencing muscle pain/soreness after moderately strenuous exercise; Subjects are excluded from the study if any of the following criteria apply: 1. Currently participating in an exercise regimen. 2. Have an allergy or intolerance to any NSAID, aspirin, acetaminophen or lactose; 3. History of rhabdomyolysis; 4. Have participated in an investigational study within the past 30 days of screening; 5. Are an employee or relative of an employee of the study site (directly involved with the study).

Locations (1)

Jean Brown Research

Salt Lake City, Utah, United States

Outcomes

Primary Outcomes

Model Sensitivity

Assess whether ibuprofen provides more relief than placebo in the DOMS model.

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.